Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants

Clinical trial NCT00348881 · COMPLETED

Trial details

NCT number: NCT00348881
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis Hepatitis B Influenza

Start date: 2006-06-01
Primary completion: 2007-10-01
Enrollment: 2133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.